Anterix (ATEX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2027, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ATEX SEC filings page.
Anterix Inc. (ATEX) reported $7.0M in revenue over the twelve months to Jun 30, 2026, up 18.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2026 reported a sudden operating profit, but only about $5.5M of operating cash arrived against $90.6M of net income.
The earnings rebound is a cash-conversion break: FY2026 net income reached$90.6M , while operating cash flow was only$5.5M . In FY2025, the company reported a net loss of$11.4M alongside operating cash flow of-$29.3M , so the latest profit surge has not yet translated proportionally into cash.
The balance sheet expanded faster through equity than liabilities in FY2026: assets rose
Revenue grew
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Anterix Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Anterix Inc.'s reported operating margin for fiscal year 2026 is above the highest share of revenue this page publishes, so the figure is not shown here. This dimension scores 74/100.
Anterix Inc.'s revenue grew 7.8% year-over-year to $6.5M, a solid pace of expansion. This earns a growth score of 86/100.
With a current ratio of 3.33, Anterix Inc. holds $3.33 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 82/100.
Anterix Inc. converts 84.3% of revenue into free cash flow ($5.5M). This strong cash generation earns a score of 100/100.
Anterix Inc.'s ROE of 34.5% shows moderate profitability relative to equity, earning a score of 44/100. This is up from -7.3% the prior year.
Anterix Inc. scores 4.61, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $1.6B against total liabilities of $202.9M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Anterix Inc. passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.
For every $1 of reported earnings, Anterix Inc. generates $0.06 in operating cash flow ($5.5M OCF vs $90.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Anterix Inc. generated $2.0M in revenue in Q1 2027. This represents an increase of 38.1% from the same quarter a year earlier. It is unchanged from the prior quarter.
Anterix Inc.'s EBITDA was -$145K in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 100.6% from the same quarter a year earlier. Against the prior quarter it is down 100.7%.
Anterix Inc. reported $240K in net income in Q1 2027. This represents a decrease of 99.0% from the same quarter a year earlier. Against the prior quarter it is down 98.7%.
Anterix Inc. earned $0.01 per diluted share (EPS) in Q1 2027. This represents a decrease of 99.3% from the same quarter a year earlier. Against the prior quarter it is down 99.0%.
Cash & Balance Sheet
Anterix Inc. generated $2.0M in free cash flow in Q1 2027, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 87.0%.
Anterix Inc. held $116.0M in cash as of Q1 2027; no long-term debt figure is on record for that period.
Not reported for Q1 2027.
Margins & Returns
Anterix Inc.'s operating margin was -12.6% in Q1 2027, reflecting core business profitability. No change is given against Q1 2026: its reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.
Anterix Inc.'s net profit margin was 12.3% in Q1 2027, showing the share of revenue converted to profit. No change is given against Q1 2026: its reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.
Anterix Inc.'s quarterly ROE was 0.1% in Q1 2027: one quarter's net income over shareholder equity, not annualized. This is down 13.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 7.0 percentage points.
Not reported for Q1 2027.
Capital Allocation
Anterix Inc. invested $1.2M in research and development in Q1 2027. This represents an increase of 8.9% from the same quarter a year earlier. Against the prior quarter it is down 3.7%.
Anterix Inc. invested $36K in capex in Q1 2027, funding long-term assets and infrastructure. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 63.6%.
Not reported for Q1 2027.
ATEX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M+38.1% | $2.0M+41.0% | $1.6M+0.4% | $1.6M+0.1% | $1.4M-7.0% | $1.4M+10.2% | $1.6M+23.2% | $1.6M+47.4% |
| R&D Expenses | $1.2M+8.9% | $1.3M+16.3% | $1.1M-1.4% | $1.2M-31.8% | $1.1M-36.0% | $1.1M-51.4% | $1.1M-9.5% | $1.8M+54.8% |
| SG&A Expenses | $11.5M-3.4% | $11.1M+2.5% | $10.1M-4.0% | $9.8M-22.8% | $11.9M-18.8% | $10.8M-4.5% | $10.5M-16.8% | $12.8M-3.5% |
| Operating Income | -$246K-101.1% | $19.8M+111.1% | -$9.1M-228.9% | $60.7Mn/m | $22.5Mn/m | $9.4Mn/m | $7.0M+625.7% | -$13.1M-681.2% |
| EBITDA | -$145K-100.6% | $19.9M+110.5% | -$9.0M-224.9% | $60.8Mn/m | $22.6Mn/m | $9.5Mn/m | $7.2M+514.7% | -$13.0M-625.9% |
| Income Tax | $374Kn/m | $1.9M+176.3% | -$2.1Mn/m | $7.5M+3168.7% | -$2.3M-284.7% | $674Kn/m | -$234K-117.5% | $230K-64.3% |
| Net Income | $240K-99.0% | $18.5M+101.1% | -$6.6M-185.6% | $53.5Mn/m | $25.2Mn/m | $9.2Mn/m | $7.7M+2250.6% | -$12.8M-715.8% |
| EPS (Basic) | $0.01-99.3% | $0.99+98.0% | -$0.35-185.4% | $2.86n/m | $1.35n/m | $0.50n/m | $0.41+1950.0% | -$0.69-727.3% |
| EPS (Diluted) | $0.01-99.3% | $0.98+96.0% | -$0.35-185.4% | $2.86n/m | $1.35n/m | $0.50n/m | $0.41+1950.0% | -$0.69-727.3% |
| Diluted Shares (Avg) | 20M+4.9% | N/A | 19M-0.5% | 19M+0.6% | 19M+1.2% | N/A | 19M-0.7% | 19M-2.7% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense.
ATEX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $497.9M+38.5% | $465.2M+39.7% | $417.0M+27.6% | $420.4M+32.5% | $359.6M+12.0% | $333.1M+2.5% | $326.7M+1.8% | $317.2M+13.3% |
| Current Assets | $153.1M+176.5% | $120.0M+97.5% | $50.1M+24.3% | $58.8M+3.6% | $55.4M-15.7% | $60.8M-16.8% | $40.3M-48.3% | $56.8M-8.6% |
| Cash & Equivalents | $116.0M+180.0% | $98.5M+108.0% | $29.5M+2.6% | $39.1M-9.4% | $41.4M-19.9% | $47.4M-21.8% | $28.8M-53.6% | $43.1M-11.1% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $212.1M+21.4% | $202.9M+14.9% | $181.1M-0.5% | $180.0M+1.0% | $174.8M+1.4% | $176.5M+7.7% | $181.9M+22.4% | $178.2M+71.7% |
| Current Liabilities | $31.5M-12.2% | $36.0M+32.3% | $36.0M+47.6% | $34.6M+119.0% | $35.9M+117.6% | $27.2M+51.5% | $24.4M+41.4% | $15.8M+3.3% |
| Non-Current Liabilities | $180.6M+30.1% | $166.9M+11.8% | $145.0M-7.9% | $145.4M-10.4% | $138.9M-10.9% | $149.3M+2.3% | $157.5M+19.9% | $162.4M+83.5% |
| Total Equity | $285.8M+54.7% | $262.3M+67.5% | $236.0M+63.0% | $240.3M+72.8% | $184.8M+24.2% | $156.6M-2.8% | $144.7M-16.0% | $139.1M-21.0% |
| Retained Earnings | -$302.1Mn/m | -$302.3Mn/m | -$320.8Mn/m | -$314.2Mn/m | -$366.8Mn/m | -$391.9Mn/m | -$399.2Mn/m | -$402.5Mn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
ATEX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0Mn/m | $15.5Mn/m | -$8.3Mn/m | $1.4Mn/m | -$3.1Mn/m | -$16.6M-369.6% | -$7.7M-122.9% | -$2.6M-125.4% |
| Depreciation & Amortization | $101K-18.5% | $103K+35.5% | $104K-26.8% | $133K-11.9% | $124K-30.7% | $76K-60.2% | $142K-28.3% | $151K-27.8% |
| Stock-Based Compensation | $3.3M-9.6% | N/A | N/A | N/A | $3.6M-16.4% | N/A | N/A | N/A |
| Capital Expenditures | $36Kn/m | $22K-52.2% | $9Kn/m | $0-100.0% | $0n/m | $46K+15.0% | $0-100.0% | $41K-78.1% |
| Free Cash Flow | $2.0Mn/m | $15.5Mn/m | -$8.3Mn/m | $1.4Mn/m | -$3.1Mn/m | -$16.6M-372.1% | -$7.7M-122.9% | -$2.7M-126.3% |
| Investing Cash Flow | -$6.7Mn/m | $46.1M+30.2% | -$2.3Mn/m | -$604Kn/m | -$2.7Mn/m | $35.4Mn/m | -$1.7Mn/m | -$5.5M-127.6% |
| Financing Cash Flow | $20.0Mn/m | $5.2Mn/m | -$10Kn/m | -$907Kn/m | -$642Kn/m | -$264Kn/m | -$4.9Mn/m | -$362Kn/m |
| Share Buybacks | N/A | $0-100.0% | $0-100.0% | $990Kn/m | $0-100.0% | $2.0M-67.3% | $4.4M-44.6% | $0-100.0% |
Not reported in any period shown, so not listed: Dividends Paid.
ATEX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.6% | 1013.0% | -576.0% | 3909.5% | 1585.4% | 676.5% | 449.0% | -846.6% |
| Net Margin | 12.3% | 945.9% | -419.6% | 3449.5% | 1775.7% | 662.9% | 492.3% | -823.1% |
| Return on Equity | 0.1%-13.6pp | 7.1%+1.2pp | -2.8%-8.1pp | 22.3%+31.4pp | 13.6%+24.1pp | 5.9%+11.7pp | 5.3%+5.1pp | -9.2%-10.4pp |
| Return on Assets | 0.1%-7.0pp | 4.0%+1.2pp | -1.6%-3.9pp | 12.7%+16.8pp | 7.0%+11.8pp | 2.8%+5.7pp | 2.4%+2.3pp | -4.0%-4.8pp |
| Current Ratio | 4.85+3.3x | 3.33+1.1x | 1.39-0.3x | 1.70-1.9x | 1.54-2.4x | 2.23-1.8x | 1.65-2.9x | 3.59-0.5x |
| Liabilities-to-Equity | 0.74-0.2x | 0.77-0.4x | 0.77-0.5x | 0.75-0.5x | 0.95-0.2x | 1.13+0.1x | 1.26+0.4x | 1.28+0.7x |
| Asset Turnover | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x |
| FCF Margin | 102.6% | 791.5% | -526.4% | 90.5% | -221.4% | -1195.2% | -491.6% | -173.4% |
Not reported in any period shown, so not listed: Gross Margin, Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Anterix Inc. ATEX | FY2026 | $6.5M | $90.6M | N/A | $1.6B | 73/100 |
| Sify Technologies Limited SIFY | FY2026 | $474.0M | -$15.0M | -3.2% | $838.8M | 38/100 |
| Shenandoah Telecom Co SHEN | FY2025 | $357.9M | -$32.9M | -9.2% | $561.4M | 28/100 |
| Cable One, Inc. CABO | FY2025 | $1.5B | -$356.5M | -23.7% | $25.4M | 32/100 |
Where Anterix Inc. Ranks
Frequently Asked Questions
What is Anterix Inc.'s annual revenue?
Anterix Inc. (ATEX) reported $6.5M in total revenue for fiscal year 2026. This represents a 7.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Anterix Inc.'s revenue growing?
Anterix Inc. (ATEX) revenue grew by 7.8% year-over-year, from $6.0M to $6.5M in fiscal year 2026.
Is Anterix Inc. profitable?
Yes, Anterix Inc. (ATEX) reported a net income of $65.7M over the trailing 12 months to June 30, 2026. In fiscal year 2026 it reported a net income of $90.6M.
What is Anterix Inc.'s EBITDA?
Anterix Inc. (ATEX) had EBITDA of $94.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Anterix Inc.'s return on equity (ROE)?
Anterix Inc. (ATEX) has a return on equity of 34.5% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Anterix Inc.'s free cash flow?
Anterix Inc. (ATEX) generated $5.5M in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Anterix Inc.'s operating cash flow?
Anterix Inc. (ATEX) generated $5.5M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Anterix Inc.'s total assets?
Anterix Inc. (ATEX) had $465.2M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Anterix Inc.'s capital expenditures?
Anterix Inc. (ATEX) invested $31K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Anterix Inc. spend on research and development?
Anterix Inc. (ATEX) invested $4.7M in research and development during fiscal year 2026.
What is Anterix Inc.'s current ratio?
Anterix Inc. (ATEX) had a current ratio of 3.33 as of fiscal year 2026, which is generally considered healthy.
What is Anterix Inc.'s liabilities-to-equity ratio?
Anterix Inc. (ATEX) had a liabilities-to-equity ratio of 0.77 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2026, because the filing data we hold for that year carries no long-term debt figure.
What is Anterix Inc.'s return on assets (ROA)?
Anterix Inc. (ATEX) had a return on assets of 19.5% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Anterix Inc.'s P/E ratio?
Anterix Inc. (ATEX) trades at 23.8x earnings, its market capitalization divided by $65.7M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.6B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Anterix Inc.'s price-to-sales ratio?
Anterix Inc. (ATEX) trades at 222x sales, its market capitalization divided by $7.0M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.6B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Anterix Inc.'s Altman Z-Score?
Anterix Inc. (ATEX) has an Altman Z-Score of 4.61, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Anterix Inc.'s Piotroski F-Score?
Anterix Inc. (ATEX) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Anterix Inc.'s earnings high quality?
Anterix Inc. (ATEX) has an earnings quality ratio of 0.06x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Anterix Inc.?
Anterix Inc. (ATEX) scores 73 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.